Finally, our results also corroborated findings in prostate cancer, in which the nuclear fraction of PRMT5 was detected in benign prostate epithelial cells and was responsible for inhibiting cell growth and limiting their proliferation, while the cytoplasmic fraction that was found in cancerous prostate tissues and promoted cell growth [12]. This evidence concerns the gene PRMT5 and prostate carcinoma.